RCM
CYTK icon

Rotella Capital Management’s Cytokinetics CYTK Stock Holding History

Rotella Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-12,778
Closed -$134K – 78
2015
Q4 		$134K Sell
12,778
-11,000
-46% -$108K 0.12% 273
2015
Q3 		$159K Buy
23,778
+8,000
+51% +$54.6K 0.05% 351
2015
Q2 		$106K Buy
15,778
+1,902
+14% +$12.5K 0.09% 267
2015
Q1 		$94K Buy
+13,876
New +$104K 0.08% 380

Other funds holding CYTK

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Rotella Capital Management's CYTK Position: Q1 2016 in Review

Rotella Capital Management sold out of Cytokinetics (CYTK) in Q1 2016, closing a stake of 12,778 shares — an estimated $134K sold.

Rotella Capital Management first reported a position in CYTK in Q1 2015 and held it in 4 quarters. The position peaked at $159K in Q3 2015. 109 funds tracked by Wall St. Rank hold CYTK as of Q1 2016.

  • Rotella Capital Management reported no remaining Cytokinetics position as of Q1 2016 after selling out during the quarter.
  • Rotella Capital Management sold 12,778 Cytokinetics shares in Q1 2016, an estimated $134K.
  • Rotella Capital Management first reported a position in Cytokinetics in Q1 2015 and held it in 4 quarters.
  • Rotella Capital Management's Cytokinetics position peaked at $159K in Q3 2015.
  • 109 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2016.

Based on Rotella Capital Management's 13F filing for Q1 2016, filed 13 May 2016.